Effect of structural modifications of ganglioside GM2 on intra-molecular carbohydrate-to-carbohydrate interaction and enzymatic susceptibility.

[1]  Michael P. Williamson,et al.  The Nuclear Overhauser Effect , 2008 .

[2]  T. Ando,et al.  Synthesis and enzymatic susceptibility of a series of novel GM2 analogs , 2006, Glycoconjugate Journal.

[3]  W. Klyne,et al.  Description of steric relationships across single bonds , 1960, Experientia.

[4]  A. Bernardi,et al.  Modeling ganglioside headgroups by conformational analysis and molecular dynamics , 2000, Glycoconjugate Journal.

[5]  R. Cole,et al.  Presence of an Unusual GM2 Derivative, Taurine-conjugated GM2, in Tay-Sachs Brain* , 2003, Journal of Biological Chemistry.

[6]  F. Rastinejad,et al.  Crystal structure of human GM2-activator protein with a novel beta-cup topology. , 2000, Journal of molecular biology.

[7]  A. Bernardi,et al.  Structural Basis for the Resistance of Tay-Sachs Ganglioside GM2 to Enzymatic Degradation* , 1999, The Journal of Biological Chemistry.

[8]  M. Kiso,et al.  Synthesis of 6'-GM2, a regioisomer of ganglioside GM2, for studying the mechanism of action of GM2 activator. , 1997, Carbohydrate research.

[9]  J. Crawley,et al.  Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Anna Bernardi,et al.  Conformational Analysis of GM1 Oligosaccharide in Water Solution with a New Set of Parameters for the Neu5Ac Moiety , 1995 .

[11]  N. V. Pavlova,et al.  Expression and specificity of human GM2 activator protein. , 1994, The Journal of biological chemistry.

[12]  L. Cantu',et al.  Aggregative properties of gangliosides in solution. , 1994, Chemistry and physics of lipids.

[13]  K. Sandhoff,et al.  Over-expression of a functionally active human GM2-activator protein in Escherichia coli. , 1993, The Biochemical journal.

[14]  K. Sandhoff,et al.  Activator proteins and topology of lysosomal sphingolipid catabolism. , 1992, Biochimica et biophysica acta.

[15]  Y. Li,et al.  Evidence for two cDNA clones encoding human GM2-activator protein. , 1992, The Biochemical journal.

[16]  A. Lamhonwah,et al.  Isolation and expression of a full-length cDNA encoding the human GM2 activator protein. , 1991, Biochemical and biophysical research communications.

[17]  R. Laine,et al.  Isolation and characterization of ceramide glycanase from the leech, Macrobdella decora. , 1989, The Journal of biological chemistry.

[18]  K. Sandhoff,et al.  Isolation of a cDNA encoding the human GM2 activator protein , 1989, FEBS letters.

[19]  L. Cantu',et al.  Light scattering measurements on gangliosides: dependence of micellar properties on molecular structure and temperature. , 1986, Chemistry and physics of lipids.

[20]  K. Nakamura,et al.  Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2. , 1984, The Journal of biological chemistry.

[21]  J. Prestegard,et al.  High-resolution proton NMR studies of gangliosides. 1. Use of homonuclear two-dimensional spin-echo J-correlated spectroscopy for determination of residue composition and anomeric configurations. , 1983, Biochemistry.

[22]  Y. Hirabayashi,et al.  The Protein Activator Specific for the Enzymic Hydrolysis of GM2 Ganglioside in Normal Human Brain and Brains of Three Types of GM2 Gangliosidosis , 1983, Journal of neurochemistry.

[23]  N. Kin,et al.  Deficiency of the Hexosaminidase A Activator Protein in a Case of GM2 Gangliosidosis; Variant AB , 1982, Pediatric Research.

[24]  Y. Hirabayashi,et al.  A protein activator for the enzymic hydrolysis of GM2 ganglioside. , 1981, The Journal of biological chemistry.

[25]  K. Sandhoff,et al.  Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A. , 1979, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[26]  K. Sandhoff,et al.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Y. Li,et al.  Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine. , 1973, The Journal of biological chemistry.

[28]  J. Månsson,et al.  Isolation and structural determination of a novel ganglioside, a disialosylpentahexosylceramide from human brain. , 1973, The Journal of biological chemistry.

[29]  R. Ledeen,et al.  Structure of the Tay-Sachs' Ganglioside. I* , 1965 .

[30]  T. Yamakawa,et al.  THE GLYCOLIPIDS OF THE BRAIN OF TAY-SACHS' DISEASE.--THE CHEMICAL STRUCTURES OF A GLOBOSIDE AND MAIN GANGLIOSIDE. , 1963, The Japanese journal of experimental medicine.

[31]  L. Svennerholm,et al.  The chemical structure of normal human brain and Tay-Sachs gangliosides. , 1962, Biochemical and biophysical research communications.